Department of Geriatrics, The First Affiliated Hospital of China Medical University, Shenyang, China.
Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China.
BMC Gastroenterol. 2022 Jun 9;22(1):292. doi: 10.1186/s12876-022-02361-3.
Malignant peritoneal mesothelioma (MPM) is a rare disease characterized by atypical symptoms, difficult diagnosis, variable course and poor prognosis, and it develops mainly in elderly individuals. The authors aimed to identify the clinical-pathological characteristics, prognosis, and prognostic factors in elderly MPM patients.
From the National Cancer Institute Surveillance Epidemiology End Results (SEER) database, 1492 patients with MPM from 1975 to 2016 were selected and divided into the elderly group (≥ 65) and the adult group (< 65). We compared the clinical-pathological characteristics and treatment methods of the elderly group (N = 665) and the adult group (N = 827). At the same time, we analysed specific selected clinicopathological parameters and prognostic factors for elderly MPM patients.
Compared with the adult group, the elderly group had higher percentages of male patients (P = 0.017) and white patients (P = 0.043) and lower proportions of insured patients (P < 0.001) married patients (P < 0.001), patients with peritoneal tumours (P = 0.006) and patients who underwent surgery (P < 0.001) and chemotherapy (P < 0.001). There was a significant difference in the differentiation grade between the two groups (P = 0.003). Elderly patients had a shorter median survival time than adult patients (6 months vs. 19 months). Uninsured (hazard ratio (HR): 5.187, P = 0.005), sarcomatoid type (HR 3.913, P < 0.001), poorly differentiated (HR 3.900, P < 0.001), distant metastasis (HR 1.735, P = 0.001), no cancer-directed surgery (HR 1.733, P < 0.001), and no chemotherapy (HR 1.532, P < 0.001) were independently associated with poorer prognosis in elderly MPM patients.
Compared with adult patients, elderly MPM patients had a higher male ratio, poor differentiation and relatively conservative treatment. The cancer-specific survival (CSS) rate of elderly MPM patients was significantly lower than that of adult patients. Insurance status, histology type, differentiation grade, stage, surgery status, and chemotherapy status were all independent prognostic factors for elderly MPM patients.
恶性腹膜间皮瘤(MPM)是一种罕见疾病,其特征为非典型症状、诊断困难、病程多变和预后不良,主要发生于老年人群。作者旨在明确老年 MPM 患者的临床病理特征、预后和预后因素。
从美国国家癌症研究所监测、流行病学和最终结果(SEER)数据库中选择了 1975 年至 2016 年间的 1492 例 MPM 患者,分为老年组(≥65 岁)和成年组(<65 岁)。我们比较了老年组(n=665)和成年组(n=827)的临床病理特征和治疗方法。同时,我们分析了老年 MPM 患者特定的选择临床病理参数和预后因素。
与成年组相比,老年组中男性(P=0.017)和白人(P=0.043)患者的比例更高,而有保险(P<0.001)、已婚(P<0.001)、腹膜肿瘤(P=0.006)和接受手术(P<0.001)和化疗(P<0.001)的患者比例更低。两组之间的分化程度存在显著差异(P=0.003)。老年患者的中位生存时间短于成年患者(6 个月 vs. 19 个月)。未投保(风险比(HR):5.187,P=0.005)、肉瘤样型(HR 3.913,P<0.001)、低分化(HR 3.900,P<0.001)、远处转移(HR 1.735,P=0.001)、无癌症导向手术(HR 1.733,P<0.001)和无化疗(HR 1.532,P<0.001)与老年 MPM 患者的不良预后独立相关。
与成年患者相比,老年 MPM 患者中男性比例较高、分化程度较差,且治疗方式相对保守。老年 MPM 患者的癌症特异性生存率(CSS)明显低于成年患者。保险状况、组织学类型、分化程度、分期、手术状态和化疗状态均是老年 MPM 患者的独立预后因素。